Feed KMDA
KM

Kamada Ltd. KMDA · NASDAQ

$7.73 -0.64% (-$0.05)

Market cap
$446.0M
Enterprise value
$428.3M
P/E
20.0x
Forward P/E
16.3x
PEG
0.6x
P/S
2.3x
P/FCF
16.8x
EV/EBITDA
10.2x
ROIC
6.9%
Gross margin
40.8%
Net margin
11.6%
Dividend yield
5.43%
Payout ratio
108.9%
Net debt/EBITDA
-0.4x
Beta
0.13
Free float
54.9%

About the company

Kamada Ltd. (KMDA) is a biopharmaceutical company engaged in research, development, and manufacturing of therapeutic products. The company specializes in the development and production of protein therapeutics and immunoglobulins for various therapeutic applications. Kamada has developed a range of biological therapeutics and products aimed at treating rare and genetic diseases, including immune deficiencies and hematological disorders. With its innovative products and meticulous research, the company maintains a significant position in the biopharmaceutical sector. Kamada Ltd. (KMDA) also has extensive collaborations with international pharmaceutical companies for the distribution of its therapeutics and the development of new treatment possibilities. Kamada Ltd. (KMDA) shares may be an attractive investment opportunity for investors interested in the biopharmaceutical sector and seeking an investment in a company with an innovative portfolio of therapeutics and potential for further growth in treatment technologies.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Amir London

Employees

462

Headquarters

Rehovot

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.